This inventor holds 47 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Gene Therapy Vectors. Top assignees: Tocagen Inc., Chiron Corporation, Gensia Pharmaceuticals, Inc.. Active years: 1990-2022.
Location History:
- San Diego, CA (US) (1990 - 2003)
- Rancho Santa Fe, CA (US) (1997 - 2022)
Company Filing History:
10 out of 12 
7 out of 672 
7 out of 14 
Years Active: 1990-2022
Areas of Expertise:
Title: The Innovative Journey of Harry E. Gruber
Introduction
Harry E. Gruber is a prolific inventor based in Rancho Santa Fe, California. With an impressive portfolio comprising 47 patents, Gruber has made substantial contributions to the fields of biotechnology and pharmaceuticals. His inventive work focuses on therapeutic solutions targeting cancer and fungal diseases, showcasing his commitment to advancing medical science.
Latest Patents
Among Gruber's latest patents are groundbreaking innovations that involve retroviral vectors and formulations of 5-fluorocytosine. One of his patents, titled "Retroviral vector having immune-stimulating activity," offers vectors designed to treat various cancers, along with methods for producing and utilizing these vectors. Another notable patent, "Formulations of 5-fluorocytosine and uses thereof," presents an extended-release formulation aimed at treating fungal diseases. This patent also details a method for treating cancer by administering an expression vector that converts 5-fluorocytosine into an active compound in cancerous cells, enhancing therapeutic efficacy.
Career Highlights
Harry Gruber has had a distinguished career, contributing his expertise to reputable companies such as Tocagen Inc. and Gensia Pharmaceuticals, Inc. His work in these organizations has significantly impacted the development of innovative therapies, underscoring his role as a leader in biotechnology.
Collaborations
Throughout his career, Gruber has collaborated with esteemed professionals in the field, including Douglas J. Jolly and Paul K. Laikind. These collaborations have enabled the amalgamation of ideas and expertise, driving the successful development of impactful medical solutions.
Conclusion
Harry E. Gruber’s journey as an inventor reflects a dedication to innovation and a passion for improving healthcare outcomes. His contributions to biotechnology, particularly through his latest patents, are poised to make a lasting impact on the treatment of cancers and fungal diseases. As research and development continue to evolve, Gruber’s work remains a testament to the power of innovation in transforming human health.